- 首页
- HSP (Heat shock proteins)
- DTHIB
DTHIB
DTHIB (Direct Targeted HSF1 InhiBitor) is a direct and selective inhibitor of heat shock factor 1 (HSF1) with Kd of 160 nM for DTHIB binding to the HSF1 DNA binding domain (DBD). DTHIB exhibits potently anticancer activities.
此产品仅用于科学研究，我们不为任何个人用途提供产品和服务
-
包装价格促销价数量
-
5mg￥987.00790.00- +
-
10mg￥1625.001300.00- +
-
25mg￥3375.002700.00- +
-
50mg￥5400.004320.00- +
-
100mg￥8637.006910.00- +
- 货号: ajcx33092
- CAS: 897326-30-6
- 别名:
- 分子式: C13H9ClFN3O3
- 分子量: 309.68
- 纯度: ＞98%
- 溶解度: DMSO : 100 mg/mL (322.91 mM; Need ultrasonic)
- 储存: Store at -20°C
- 库存: 现货
Background
DTHIB (Direct Targeted HSF1 InhiBitor) is a direct and selective inhibitor of heat shock factor 1 (HSF1) with Kd of 160 nM for DTHIB binding to the HSF1 DNA binding domain (DBD). DTHIB exhibits potently anticancer activities.
Direct Targeted HSF1 InhiBitor (DTHIB) physically engages HSF1 and selectively stimulates degradation of nuclear HSF1. DTHIB robustly inhibits the HSF1 cancer gene signature and prostate cancer cell proliferation.[1]
DTHIB potently attenuates tumor progression in four therapy-resistant prostate cancer animal models, including an NEPC model, where it causes profound tumor regression.[1]
[1] Bushu Dong, et al. Sci Transl Med. 2020 Dec 16;12(574):eabb5647.
